Tapewire

NYSE · USD

ZBH

ZIMMER BIOMET HOLDINGS, INC.

Export transactions ↓
Tapewire entity
3278
SEC CIK
0001136869
Parsed reports
830

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2025 Filed Jul 2, 2025 20:29 UTC GrantPhantom Stock Units · Derivative 178.355 $0.00 Strike: $91.11 $0.00
Disclosure

SEC source: 0001062993-25-012457 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,153.79

Underlying: Common Stock · 178.355 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 20:28 UTC GrantPhantom Stock Units · Derivative 171.496 $0.00 Strike: $91.11 $0.00
Disclosure

SEC source: 0001062993-25-012455 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,221.199

Underlying: Common Stock · 171.496 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 20:26 UTC GrantPhantom Stock Units · Derivative 150.916 $0.00 Strike: $91.11 $0.00
Disclosure

SEC source: 0001062993-25-012452 · form4.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,470.296

Underlying: Common Stock · 150.916 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:06 UTC
Yi SangGroup President, Asia Pacific
SaleCommon Stock 800 $92.51 $74,011.20
Disclosure

SEC source: 0001062993-25-011810 · form4.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,624

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:39 UTC
Yi SangGroup President, Asia Pacific
SaleCommon Stock 1,000 $95.00 $95,000.00
Disclosure

SEC source: 0001062993-25-011674 · form4.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,424

Read SEC document
June 01, 2025 Filed Jun 3, 2025 20:38 UTC
Stellato Paul AVP, Controller & CAO
Exercise / conversionRestricted Stock Units · Derivative 626 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010833 · form4.xml · derivative · entry 3

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: One-third of the RSUs vested on each of June 1, 2023, June 1, 2024 and June 1, 2025.

F3 · derivative.expiration_date: One-third of the RSUs vested on each of June 1, 2023, June 1, 2024 and June 1, 2025.

Read SEC document
June 01, 2025 Filed Jun 3, 2025 20:38 UTC
Stellato Paul AVP, Controller & CAO
Tax withholdingCommon Stock 197 $92.24 $18,171.28
Disclosure

SEC source: 0001062993-25-010833 · form4.xml · nonDerivative · entry 2

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,772

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
June 01, 2025 Filed Jun 3, 2025 20:38 UTC
Stellato Paul AVP, Controller & CAO
Exercise / conversionCommon Stock 626 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010833 · form4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,969

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 23:21 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010736 · form4.xml · derivative · entry 2

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,239.726

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 23:21 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010736 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,427.538

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 36.578 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 23:19 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010734 · form4.xml · derivative · entry 2

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,580.726

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 23:19 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010734 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,134.921

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: These units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 21.839 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:48 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010731 · form4.xml · derivative · entry 2

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,404.798

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:48 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010731 · form4.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,319.38

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 1.192 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:47 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010729 · form4.xml · derivative · entry 2

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,357.726

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:47 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010729 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,049.703

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 9.929 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:47 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010728 · form4.xml · derivative · entry 2

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,580.726

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:47 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010728 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,975.435

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 14.439 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:46 UTC GrantRestricted Stock Units · Derivative 1,404.798 $5.00 $7,023.99
Disclosure

SEC source: 0001062993-25-010725 · form4.xml · derivative · entry 2

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,864.726

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:46 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010725 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,904.384

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 79.853 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:44 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010721 · form4.xml · derivative · entry 2

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,409.726

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:44 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010721 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,477.633

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 69.485 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:43 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010718 · form4.xml · derivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,988.726

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:43 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010718 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,485.689

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 46.082 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:43 UTC GrantRestricted Stock Units · Derivative 1,404.798 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-010717 · form4.xml · derivative · entry 2

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,473.789

Underlying: Common Stock · 1,404.798 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:43 UTC GrantPhantom Stock Units · Derivative 810.46 $0.00 Strike: $92.54 $0.00
Disclosure

SEC source: 0001062993-25-010717 · form4.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,046.114

Underlying: Common Stock · 810.46 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 2.894 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 21:06 UTC
Noor JehanzebSee remarks below.
GrantRestricted Stock Units · Derivative 19,875 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-006996 · form4.xml · derivative · entry 1

Noor Jehanzeb · CIK 0002059755 · See remarks below.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,875

Underlying: Common Stock · 19,875 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing April 1, 2026.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing April 1, 2026.

Read SEC document
March 31, 2025 Filed Apr 3, 2025 00:40 UTC GrantPhantom Stock Units · Derivative 288.863 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006908 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,580.5

Underlying: Common Stock · 288.863 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 32.604 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:11 UTC GrantPhantom Stock Units · Derivative 533.286 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006824 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,937.582

Underlying: Common Stock · 533.286 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 45.338 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:10 UTC GrantPhantom Stock Units · Derivative 299.974 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006822 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,597.688

Underlying: Common Stock · 299.974 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 63.054 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:09 UTC GrantPhantom Stock Units · Derivative 244.423 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006821 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,014.071

Underlying: Common Stock · 244.423 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 72.913 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:07 UTC GrantPhantom Stock Units · Derivative 138.876 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006819 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,229.314

Underlying: Common Stock · 138.876 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 8.579 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:07 UTC GrantPhantom Stock Units · Derivative 244.423 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006820 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,302.622

Underlying: Common Stock · 244.423 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 19.144 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:04 UTC GrantPhantom Stock Units · Derivative 122.211 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006816 · form4.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,232.76

Underlying: Common Stock · 122.211 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 2.133 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:03 UTC GrantPhantom Stock Units · Derivative 122.211 $0.00 Strike: $112.51 $0.00
Disclosure

SEC source: 0001062993-25-006815 · form4.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 507.728

Underlying: Common Stock · 122.211 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 0.556 phantom stock units accrued January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:53 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Exercise / conversionRestricted Stock Units · Derivative 2,094 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004989 · form4.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,094

Underlying: Common Stock · 2,094 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 2,094 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026.

F3 · derivative.expiration_date: 2,094 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:53 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Tax withholdingCommon Stock 824 $104.86 $86,404.64
Disclosure

SEC source: 0001062993-25-004989 · form4.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,038

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:53 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Exercise / conversionCommon Stock 2,094 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004989 · form4.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:39 UTC
Bezjak MarkPresident, Americas
Exercise / conversionRestricted Stock Units · Derivative 1,621 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004977 · form4.xml · derivative · entry 3

Bezjak Mark · CIK 0002004536 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,621

Underlying: Common Stock · 1,621 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 1,621 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026.

F3 · derivative.expiration_date: 1,621 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:39 UTC
Bezjak MarkPresident, Americas
Tax withholdingCommon Stock 638 $104.86 $66,900.68
Disclosure

SEC source: 0001062993-25-004977 · form4.xml · nonDerivative · entry 2

Bezjak Mark · CIK 0002004536 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,134

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:39 UTC
Bezjak MarkPresident, Americas
Exercise / conversionCommon Stock 1,621 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004977 · form4.xml · nonDerivative · entry 1

Bezjak Mark · CIK 0002004536 · President, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:38 UTC
Stellato Paul AVP, Controller & CAO
Exercise / conversionRestricted Stock Units · Derivative 608 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004975 · form4.xml · derivative · entry 3

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 607

Underlying: Common Stock · 608 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 608 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026

F3 · derivative.expiration_date: 608 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:38 UTC
Stellato Paul AVP, Controller & CAO
Tax withholdingCommon Stock 191 $104.86 $20,028.26
Disclosure

SEC source: 0001062993-25-004975 · form4.xml · nonDerivative · entry 2

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,343

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:38 UTC
Stellato Paul AVP, Controller & CAO
Exercise / conversionCommon Stock 608 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004975 · form4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:37 UTC
Winkler LoriSVP and CHRO
Exercise / conversionRestricted Stock Units · Derivative 1,757 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004974 · form4.xml · derivative · entry 4

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,756

Underlying: Common Stock · 1,757 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 1,757 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026

F3 · derivative.expiration_date: 1,757 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:37 UTC
Winkler LoriSVP and CHRO
Tax withholdingCommon Stock 692 $104.86 $72,563.12
Disclosure

SEC source: 0001062993-25-004974 · form4.xml · nonDerivative · entry 3

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,833

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:37 UTC
Winkler LoriSVP and CHRO
Exercise / conversionCommon Stock 1,757 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004974 · form4.xml · nonDerivative · entry 2

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,525

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:36 UTC
VAN ZUILEN WILFREDGroup Pres, EMEA
Exercise / conversionRestricted Stock Units · Derivative 2,162 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004973 · form4.xml · derivative · entry 3

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,161

Underlying: Common Stock · 2,162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 2,162 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026

F3 · derivative.expiration_date: 2,162 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:36 UTC
VAN ZUILEN WILFREDGroup Pres, EMEA
Tax withholdingCommon Stock 569 $104.86 $59,665.34
Disclosure

SEC source: 0001062993-25-004973 · form4.xml · nonDerivative · entry 2

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,534

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:36 UTC
VAN ZUILEN WILFREDGroup Pres, EMEA
Exercise / conversionCommon Stock 2,162 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-004973 · form4.xml · nonDerivative · entry 1

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.